The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Compounded "semaglutide" is not FDA approved semaglutide.com FDA mulls compounding for peptides previously flagged over safety risks BioSpace FDA to weigh easing limits on unproven peptides promoted by RFK Jr.